| Esophageal cancer: emerging therapeutics JE Rogers, M Sewastjanow-Silva, RE Waters, JA Ajani Expert opinion on therapeutic targets 26 (2), 107-117, 2022 | 62 | 2022 |
| Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment Y Fan, Y Li, X Yao, J Jin, A Scott, B Liu, S Wang, L Huo, Y Wang, R Wang, ... Gut 72 (4), 624-637, 2023 | 30 | 2023 |
| Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma D Hao, S He, K Harada, MP Pizzi, Y Lu, P Guan, L Chen, R Wang, ... Gut 70 (11), 2055-2065, 2021 | 25 | 2021 |
| Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, ... Cancer cell 41 (8), 1407-1426. e9, 2023 | 16 | 2023 |
| Challenges and Prospects of Patient-Derived Xenografts for Cancer Research J Jin, K Yoshimura, M Sewastjanow-Silva, S Song, JA Ajani Cancers 15 (17), 4352, 2023 | 13 | 2023 |
| Esophageal cancer: Is the CROSS strategy ready for history books? MDS Sewastjanow, JE Rogers, WL Hofstetter, JA Ajani The Journal of Thoracic and Cardiovascular Surgery 165 (3), 901-905, 2023 | 4 | 2023 |
| GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma Y Li, Y Fan, J Xu, L Huo, AW Scott, J Jin, B Yang, S Shao, L Ma, Y Wang, ... Journal of Experimental & Clinical Cancer Research 41 (1), 257, 2022 | 4 | 2022 |
| Diagnostic value of the reaction at the Bacillus Calmette-Guérin vaccination site in Kawasaki disease LMO Diniz, RG Castanheira, YG Giampietro, MS Silva, FD Nogueira, ... Revista Paulista de Pediatria 39, e2019338, 2020 | 4 | 2020 |
| Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target JE Rogers, K Yamashita, M Sewastjanow-Silva, A Trail, RE Waters, ... Cancers 15 (21), 5180, 2023 | 3 | 2023 |
| Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives N Charalampakis, S Tsakatikas, D Schizas, S Kykalos, M Tolia, ... World Journal of Gastrointestinal Oncology 14 (1), 181, 2022 | 3 | 2022 |
| A new intronic quantitative PCR method led to the discovery of transformation from human ascites to murine malignancy in a mouse model J Jin, L Huo, Y Fan, R Wang, AW Scott, MP Pizzi, X Yao, S Shao, L Ma, ... Frontiers in Oncology 13, 1062424, 2023 | 1 | 2023 |
| Phase I trial of perioperative chemotherapy plus immunotherapy in localized esophageal and gastroesophageal adenocarcinoma. MA Blum Murphy, GM Nogueras Gonzalez, M Sewastjanow-Silva, ... Journal of Clinical Oncology 41 (4_suppl), 400-400, 2023 | 1 | 2023 |
| Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in Gastric and Gastroesophageal Junction Adenocarcinoma R Waters, M Sewastjanow-Silva, K Yamashita, A Abdelhakeem, KK Iwata, ... JCO Precision Oncology 8, e2300543, 2024 | | 2024 |
| Chemotherapy Plus Atezolizumab Pre-and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study M Sewastjanow-Silva, L Xiao, GN Gonzalez, X Wang, W Hofstetter, ... Cancers 16 (7), 1378, 2024 | | 2024 |
| SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel K Yamashita, M Sewastjanow-Silva, K Yoshimura, JE Rogers, ... Cancers 16 (7), 1300, 2024 | | 2024 |
| Scales and quotient ADHD system properties: a correlation study MIC Araújo, B Bragança, PHP de Moraes, JJ de Paula, MS da Silva, ... Debates em Psiquiatria 13, 1-12, 2023 | | 2023 |
| Nivolumab combination therapy as first-line treatments for unresectable, advanced or metastatic esophageal squamous cell carcinoma JE Rogers, K Yamashita, M Sewastjanow-Silva, E Rosa Vicentini, ... Expert review of anticancer therapy 23 (6), 565-571, 2023 | | 2023 |
| Evolution of immune and stromal cell states during the gastric cancer continuum R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, ... Cancer Research 83 (7_Supplement), 1194-1194, 2023 | | 2023 |
| Claudin 18.2 (CLDN18. 2) expression prevalence, prognostication and clinical variables in gastric and gastroesophageal junction adenocarcinoma patient samples M Sewastjanow, K Yamashita, KK Iwata, D Moran, D Elsouda, M Pizzi, ... Cancer Research 83 (7_Supplement), 2141-2141, 2023 | | 2023 |
| A liquid biopsy approach to gastric cancer reveals a signature reflective of epithelial to mesenchymal transition AHA Sater, Y Chen, JF Fahrmann, E Irajizad, Y Cai, F Hsiao, JV Vykoukal, ... Cancer Research 83 (7_Supplement), 2017-2017, 2023 | | 2023 |
Jaffer AjaniUT M. D. Anderson Cancer CenterVerified email at mdanderson.org
